Juniarto, A.Z. et al. 2014. Salivary 17-hydroxyprogesterone (17-OHP) and androstenedione in monitoring efficacy of treatment among Indonesian Congenital Adrenal Hyperplasia Patients. Journal of the ASEAN Federation of Endocrine Societies. 27, 2 (May 2014), 203.